This book analyzes the profit-driven nature of the pharmaceutical industry to explore how healthcare has become commodified in the United States. It addresses how pharmaceutical companies are shaping drug interventions, such as the ways in which pharmaceutical advertisements frame issues of identity and representation for patients and healthcare.